Generation and Characterization of a Novel Cyp2a(4/5)bgs-Null Mouse Model
Authors:
- Yuan WeiYWYuan Wei
- Lei LiLLLei Li
- Xin ZhouXZXin Zhou
- Qing-Yu ZhangQZQing-Yu Zhang
- Anwar DunbarADAnwar Dunbar
- Fang LiuFLFang Liu
- Kerri KluetzmanKKKerri Kluetzman
- Weizhu YangWYWeizhu Yang
- Xinxin DingXDXinxin Ding
- 1 January 2013
- journal article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 41 (1) , 132-140
Abstract
Knockout mouse models targeting various cytochrome P450 (P450 or CYP) genes are valuable for determining P450's biologic functions, including roles in drug metabolism and chemical toxicity. In this study, a novel Cyp2a(4/5)bgs-null mouse model was generated, in which a 1.2-megabase pair genomic fragment containing nine Cyp genes in mouse chromosome 7 (including, sequentially, Cyp2a5, 2g1, 2b19, 2b23, 2a4, 2b9, 2b13, 2b10, and 2s1) are deleted, through Cre-mediated recombination in vivo. The resultant mouse strain was viable and fertile, without any developmental deficits or morphologic abnormalities. Deletion of the constitutive genes in the cluster was confirmed by polymerase chain reaction analysis of the genes and the mRNAs in tissues known to express each gene. The loss of this gene cluster led to significant decreases in microsomal activities toward testosterone hydroxylation in various tissues examined, including olfactory mucosa (OM), lung, liver, and brain. In addition, systemic clearance of pentobarbital was decreased in Cyp2a(4/5)bgs-null mice, as indicated by >60% increases in pentobarbital-induced sleeping time, compared with wild-type (WT) mice. This novel Cyp2a(4/5)bgs-null mouse model will be valuable for in vivo studies of drug metabolism and chemical toxicities in various tissues, including the liver, lung, brain, intestine, kidney, skin, and OM, where one or more of the targeted Cyp genes are known to be expressed in WT mice. The model will also be valuable for preparation of humanized mice that express human CYP2A6, CYP2A13, CYP2B6, or CYP2S1, and as a knockout mouse model for five non-P450 genes (Vmn1r184, Nalp9c, Nalp4a, Nalp9a, and Vmn1r185) that were also deleted.Keywords
This publication has 61 references indexed in Scilit:
- Cytochrome P450 enzymes in the brain: emerging evidence of biological significanceTrends in Pharmacological Sciences, 2011
- Lentiviral-Mediated RNAi Knockdown Yields a Novel Mouse Model for Studying Cyp2b FunctionToxicological Sciences, 2011
- A Novel Defensive Mechanism against Acetaminophen Toxicity in the Mouse Lateral Nasal Gland: Role of CYP2A5-Mediated Regulation of Testosterone Homeostasis and Salivary Androgen-Binding Protein ExpressionMolecular Pharmacology, 2011
- Mechanisms of olfactory toxicity of the herbicide 2,6-dichlorobenzonitrile: Essential roles of CYP2A5 and target-tissue metabolic activationToxicology and Applied Pharmacology, 2010
- Generation of a Mouse Model with a Reversible Hypomorphic Cytochrome P450 Reductase Gene: Utility for Tissue-Specific Rescue of the Reductase Expression, and Insights from a Resultant Mouse Model with Global Suppression of P450 Reductase Expression in Extrahepatic TissuesThe Journal of Pharmacology and Experimental Therapeutics, 2010
- Opioids activate brain analgesic circuits through cytochrome P450/epoxygenase signalingNature Neuroscience, 2010
- Role of CYP2A5 in the Clearance of Nicotine and Cotinine: Insights from Studies on a Cyp2a5-null Mouse ModelThe Journal of Pharmacology and Experimental Therapeutics, 2010
- High abundance of testosterone and salivary androgen-binding protein in the lateral nasal gland of male miceThe Journal of Steroid Biochemistry and Molecular Biology, 2009
- An Intestinal Epithelium-Specific Cytochrome P450 (P450) Reductase-Knockout Mouse Model: Direct Evidence for a Role of Intestinal P450s in First-Pass Clearance of Oral NifedipineDrug Metabolism and Disposition, 2009
- Acre-transgenic mouse strain for the ubiquitous deletion ofloxP-flanked gene segments including deletion in germ cellsNucleic Acids Research, 1995